Selection of a surrogate β-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem-Reference-Cited by-同舟云学术

Selection of a surrogate β-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem

Published:2007-12 Issue:4 Volume:59 Page:467-472
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Jones Ronald N.,Sader Helio S.,Fritsche Thomas R.,Janechek Michael J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Cross susceptibility and absence of cross resistance to cefotetan and cefoxitin;Barry;J. Clin. Microbiol.,1987

2. Use of pharmacokinetic–pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem;Bhavnani;Antimicrob. Agents Chemother.,2005

3. Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control;Brown;J. Antimicrob. Chemother.,2005

4. In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis;Chen;Antimicrob. Agents Chemother.,2005

5. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved standard, M7-A7;Clinical and Laboratory Standards Institute,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report;Future Microbiology;2017-12

2. Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin;Diagnostic Microbiology and Infectious Disease;2015-05

3. Use of In Vitro Vancomycin Testing Results To Predict Susceptibility to Oritavancin, a New Long-Acting Lipoglycopeptide;Antimicrobial Agents and Chemotherapy;2015-04

4. Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species;Diagnostic Microbiology and Infectious Disease;2013-01

5. Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa;Diagnostic Microbiology and Infectious Disease;2012-03